We report evidence, confirmed by the lack of travel activity outside of France and genetic diversity analysis using polymorphic microsatellite markers, that malaria infection effectively treated with an artemisinin-based combination can remain dormant and relapse during pregnancy at least 2 years after treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786779 | PMC |
http://dx.doi.org/10.1128/AAC.01892-17 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!